Real-time enrollment status for this secondary progressive multiple sclerosis (spms) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07225504 |
| Recruiting Status | Recruiting |
| Condition | Secondary Progressive Multiple Sclerosis (SPMS) |
| Phase | PHASE3 |
| Target Enrollment | 1,275 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 13, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07225504 is currently recruiting participants. This phase3 study for secondary progressive multiple sclerosis (spms) is actively seeking new participants at 43 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07225504 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07225504 was last updated 1 week ago (October 13, 2026). HelloStudys verifies this status automatically.